Its significant upregulation, strong association with inflammation-linked immune cell populations, and involvement in PI3K/AKT/mTOR signaling indicate that PIK3R1 may influence immune activation, tissue damage, and fibrofatty replacement characteristic of ARVC. Here, PIK3R1 is linked to arrhythmogenic right ventricular cardiomyopathy.